Back to results
US 12,157,772 B2Granted
Prophylactic agent, onset-suppressing agent or therapeutic agent for progressive immune demyelinating diseases
AssigneeNational Center of Neurology and Psychiatry
InventorsShinji Oki, Takashi Yamamura
Life of this patent
Estimating the term…
Abstract
The present invention provides a prophylactic agent, onset-suppressing agent, or therapeutic agent for progressive immune demyelinating diseases comprising, as an active ingredient, a substance capable of suppressing or inhibiting production of prolactin.
Claims1
A method for treating progressive multiple sclerosis (MS) in a subject suffering from progressive MS, by decreasing Eomes-expressing T helper (Th) cells in the subject, the method comprising:
- administering, to the subject, an anti-CX3CR1 antibody or an antigen-binding fragment thereof.
Dependencies are inferred from the claim text.